School of Medicine
Showing 2,621-2,640 of 5,184 Results
-
Joseph Levitt, MD, MS
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsMy research focuses on the physiolgogic and biomarker characteristics of early acute lung injury (ALI) prior to need for mechanical ventilation. While, to date no pharmacologic treatment has improved survival in ALI, following the paradigm of early goal directed therapy for severe sepsis, clinical benefit may derive from identifying patients and initiating treatment prior to the need for positive pressure ventilation (and therefore prior to meeting current study entry criteria).
-
Lee Levitt
Professor of Medicine (Hematology) at the Santa Clara Valley Medical Center, Emeritus
Current Research and Scholarly InterestsLow molecular-weight heparins Clinical trials with anti-thrombotics Clinical trials in patients with leukemia, breast cancer and myeloma Medical education.
-
Michael Levitt
Robert W. and Vivian K. Cahill Professor of Cancer Research
Current Research and Scholarly InterestsStanford Professor of Biophysics and Computational Biology, Cambridge PhD and DSc, 2013 Chemistry Nobel Laureate (complex systems), FRS & US National Academy member, I code well for my age.
-
Maayan Levy
Associate Professor of Pathology
Current Research and Scholarly InterestsThe Levy Lab studies how microbiome-brain interactions influence metabolism, behavior, and disease. By investigating how microbial signals affect neural circuits, we explore mechanisms underlying obesity, diabetes, and psychiatric conditions. The lab seeks to uncover new therapeutic targets using advanced neuroscience tools like optogenetics and imaging. Our research aims to improve understanding of how microbiome imbalances contribute to disease and how restoring balance can promote health.
-
Richard Jonathan Levy
Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric) and, by courtesy, of Pediatrics (Cardiology)
BioRichard J. Levy, MD, FAAP is Professor at Stanford University School of Medicine and Chief of Pediatric Cardiac Anesthesiology at Lucile Packard Children’s Hospital. He has been an NIH-funded clinician-scientist for over 20 years. His laboratory currently investigates the toxicity of anesthetics in the developing brain and heart along with mitochondrial mechanisms of anesthesia. He is currently funded to study and develop a benzoquinone molecule as a novel anesthetic. He is an Associate Editor for Frontiers in Pediatrics, Frontiers in Cardiovascular Medicine, and Survey of Anesthesiology and serves as a regular reviewer for Anesthesiology, British Journal of Anaesthesiology, Critical Care Medicine, Anesthesia & Analgesia, Neurotoxicology and Teratology, PLOS One, The Journal of Thoracic and Cardiovascular Surgery, World Journal for Pediatric and Congenital Heart Surgery, and the American Journal of Physiology. In addition, Dr. Levy has served as an ad hoc reviewer for Science, Nature Medicine, Scientific Reports, and Nature Reviews Cardiology.
-
Ronald Levy, MD
Robert K. and Helen K. Summy Professor in the School of Medicine
Current Research and Scholarly InterestsClinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer.
-
David B. Lewis
Naddisy Foundation Professor of Pediatric Food Allergy, Immunology, and Asthma
Current Research and Scholarly InterestsMy laboratory is focused on defining cellular and molecular mechanisms that limit T cell responses to vaccines and pathogens during normal early postnatal development and in cases of inherited genetic immunodeficiencies. We are also determinomg how these limitations in immunity can be overcome by using novel approaches for vaccine adjuvants for influenza vaccine and by using catalytically inactive Cas proteins for inducing endogenous gene expression.
-
Eldrin F. Lewis, MD, MPH
Simon H. Stertzer, MD, Professor
BioDr. Lewis is a board-certified, fellowship-trained specialist in cardiovascular medicine. He is the chief of the Division of Cardiovascular Medicine and a professor of cardiovascular medicine.
Dr. Lewis is an esteemed clinician-scientist who specializes in the care of patients with advanced heart failure. He is an internationally recognized expert on heart failure, heart transplant, and quality of life for heart failure patients. He cares deeply about his patients as well as his colleagues, the hospital, and the School of Medicine. Dr. Lewis is committed to diversity and inclusion, as well as expanding Stanford clinical research initiatives.
A fundamental principle of Dr. Lewis’ practice is his belief that “there is more to life than death,” that cardiovascular care should go beyond helping patients survive to also helping them enjoy the best possible quality of life.
Dr. Lewis has deep expertise in conducting clinical trials examining diagnostic and therapeutic approaches to heart failure. He has done innovative work to create systems for incorporating quality of life measures for cardiovascular patients into electronic health records. This research has received support from the National Heart, Lung and Blood Institute and the National Institutes of Health.
Much of his quality of life research has focused on patient-reported outcomes. Dr. Lewis emphasizes the importance of looking at how a disease, whether chronic or acute, impacts people’s ability to function and perform their activities of daily living. Strategies to improve patients’ well-being focus not only on their physical symptoms but also on depression, anxiety, exercise capacity, and ability to function in daily living.
Dr. Lewis’ commitment to expanding clinical research initiatives will give patients more opportunities to participate in the clinical trials and access the latest care strategies that can translate into better outcomes. The goal is early access to the most advanced technology, pharmacology, and device therapy that can change outcomes for the better. He also envisions forming closer partnerships with community cardiologists and capitalizing further on Stanford’s proximity to and unique relationships with the digital technology leaders of Silicon Valley to enhance the use of digital technology for monitoring patients, optimizing treatment, and tracking outcomes.
He has authored nearly 200 articles published in peer-reviewed journals including the New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, JAMA Cardiology, JAMA Internal Medicine, and many more. He is also on multiple editorial boards for cardiovascular journals and was an associate editor for Circulation–Heart Failure. In addition, he is an author of professional society clinical practice guidelines and scientific statements from both the American Heart Association (AHA) and the Food and Drug Administration.
Dr. Lewis’ honors for clinical care, scholarship, and research include the Joel Gordon Miller Award for community service and leadership from the University of Pennsylvania School of Medicine. He also was one of the first recipients of the Minority Faculty Development Award, which recognizes the research potential of young physicians. Dr. Lewis has received a grant from the Robert Wood Johnson Foundation to study the role of quality of life assessment in clinical decision making in patients with heart failure.
He is a fellow of the American College of Cardiology and the National American Heart Association (AHA) Research Committee. In addition, Dr. Lewis was as a member of the AHA Founders Affiliate Board of Directors, chair of the Council on Clinical Cardiology, and research chair of the Association of Black Cardiologists. He also serves on scientific committees to review grants for the AHA and on the FDA Task Force for the Standardization of Definitions for Endpoint Events in Cardiovascular Trials. -
Matt Lewis, MD, MPH
Clinical Associate Professor, Dermatology
BioDr. Lewis specializes in autoimmune skin diseases. He completed medical school at The George Washington University School of Medicine and dermatology residency at The University of Rochester, where he was chief resident. He also completed a Master’s of Public Health at Johns Hopkins and a fellowship in autoimmune connective tissue diseases at Stanford University.
He believes multidisciplinary care is key to treat patients with systemic inflammatory diseases. He holds a rheumatology-dermatology clinic with a rheumatologist, Dr. Janice Lin, as well as a dermatology-ophthalmology clinic with an ophthalmologist, Dr. Christopher Ta, and is the dermatologist for the sarcoidosis program, all with this primary goal of providing high quality, collaborative, patient-centered care. -
Richard Lewis
Professor of Molecular and Cellular Physiology, Emeritus
Current Research and Scholarly InterestsWe study molecular mechanisms of calcium signaling with a focus on store-operated CRAC channels and their essential roles in T cell development and function. Currently we aim to define the molecular mechanism for CRAC channel activation and the means by which calcium signal dynamics mediate specific activation of transcription factors and T-cell genes during development.
